BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10329404)

  • 1. Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.
    Kato K; Satoh H; Endo Y; Yamada D; Midorikawa S; Sato W; Mizuno K; Fujita T; Tsukamoto K; Watanabe T
    Biochem Biophys Res Commun; 1999 May; 258(2):431-5. PubMed ID: 10329404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
    Hamaguchi E; Takamura T; Shimizu A; Nagai Y
    J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium.
    Chen NG; Han X
    Biochem Biophys Res Commun; 2001 Apr; 282(3):717-22. PubMed ID: 11401521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor alpha in human endothelial cells increases plasminogen activator inhibitor type-1 expression.
    Ye P; Hu X; Liu Y; Zhao Y
    Chin Med J (Engl); 2003 Jan; 116(1):29-33. PubMed ID: 12667383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
    Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells.
    Chiba Y; Ogita T; Ando K; Fujita T
    Biochem Biophys Res Commun; 2001 Aug; 286(3):541-6. PubMed ID: 11511093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma mediated inhibition of plasminogen activator inhibitor type 1 production and proliferation of human umbilical vein endothelial cells.
    Hong HK; Cho YM; Park KH; Lee CT; Lee HK; Park KS
    Diabetes Res Clin Pract; 2003 Oct; 62(1):1-8. PubMed ID: 14581151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression.
    Chen NG; Sarabia SF; Malloy PJ; Zhao XY; Feldman D; Reaven GM
    Biochem Biophys Res Commun; 1999 Oct; 263(3):718-22. PubMed ID: 10512746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.
    Satoh H; Tsukamoto K; Hashimoto Y; Hashimoto N; Togo M; Hara M; Maekawa H; Isoo N; Kimura S; Watanabe T
    Biochem Biophys Res Commun; 1999 Jan; 254(3):757-63. PubMed ID: 9920814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells.
    Yamakawa K; Hosoi M; Koyama H; Tanaka S; Fukumoto S; Morii H; Nishizawa Y
    Biochem Biophys Res Commun; 2000 May; 271(3):571-4. PubMed ID: 10814503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: impact of endotoxin and tumor necrosis factor-alpha.
    Muth H; Maus U; Wygrecka M; Lohmeyer J; Grimminger F; Seeger W; Günther A
    Crit Care Med; 2004 Jan; 32(1):217-26. PubMed ID: 14707582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 attenuates tumour necrosis factor-alpha-mediated induction of plasminogen [corrected] activator inhibitor-1 expression.
    Liu H; Hu Y; Simpson RW; Dear AE
    J Endocrinol; 2008 Jan; 196(1):57-65. PubMed ID: 18180317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone reduces plasminogen activator inhibitor-1 expression and secretion in cultured human adipocytes.
    Gottschling-Zeller H; Röhrig K; Hauner H
    Diabetologia; 2000 Mar; 43(3):377-83. PubMed ID: 10768100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
    Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S
    Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARγ-independent thiazolidinedione-mediated inhibition of NUR77 expression in vascular endothelial cells.
    Hu Y; Liu HB; Simpson RW; Dear AE
    J Endocrinol; 2011 Jan; 208(1):R1-7. PubMed ID: 20978184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
    Louise CB; Obrig TG
    Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine regulation of the synthesis of plasminogen activator inhibitor-2 by human vascular endothelial cells. Comparison with plasminogen activator inhibitor-1 synthesis.
    Zoellner H; Wojta J; Gallicchio M; McGrath K; Hamilton JA
    Thromb Haemost; 1993 Feb; 69(2):135-40. PubMed ID: 8456426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro.
    He G; Pedersen SB; Bruun JM; Lihn AS; Richelsen B
    Horm Metab Res; 2003 Jan; 35(1):18-23. PubMed ID: 12669266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.